LLY compared with VRTX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

VRTXVertex Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

VRTXVertex Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

VRTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±4.9%▼−4.05%×0.82

Q2 FY26±5.2%▲+1.70%×0.33

= impliedLLY realized, solidVRTX realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.4%

▼−1.28%

×0.24

Feb 13 '26±6.0%▲+5.69%×0.95

LLYELI Lilly & Co

1,369.79▲+0.37%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

VRTXVertex Pharmaceuticals Inc

538.60▼−0.72%

Regular sessionNov 6 '26

Mkt cap$139.2BRevenue$3.4BQ3 FY26Revenue$12.0BFY25

Compare

Regular sessionNov 6 '26

LLYELI Lilly & Co

VRTXVertex Pharmaceuticals Inc

1,369.79▲+0.37%

Price

538.60▼−0.72%

$1.2T

Mkt cap

$139.2B

Q3 FY26$24.4B

Revenue

$3.4BQ3 FY26

FY25$65.2B

Revenue

$12.0BFY25

LLY1,369.79▲+0.37%vsVRTX538.60▼−0.72%Regular sessionNov 6 '26